The Aplio 500 CV and 300 CV, which features Toshiba’s 2D Wall Motion Tracking technology, are premier systems for all 2D cardiovascular exams.
With the 2D Wall Motion Tracking technology, the Aplio 500 CV and 300 CV systems provide exceptional visualization and quantitative analysis of myocardial wall motion with accuracy and reproducibility.
Toshiba has developed the Aplio CV systems to provide comprehensive information at the patient’s bedside through the use of on-board cardiac quantification measurements in all directions (radial, circumferential, 2D rotation and longitudinal).
The Aplio Artida cardiovascular ultrasound system features Toshiba’s 3D Wall Motion Tracking software that provides accurate and reproducible quantitative analysis of cardiac function.
According to Toshiba, clinicians can obtain high-quality 3D images on a wider range of patients, including those with arrhythmias and shortness of breath, with the enhanced single-beat 3D acquisition of Artida.
Toshiba Ultrasound business unit director Tomohiro Hasegawa said that the company’s ultrasound systems with Wall Motion Tracking are designed to put customers first, providing clear imaging for improved diagnoses on every exam.
"Physicians are given exceptional image quality, which helps to identify early stages of cardiac disease for better patient care," Hasegawa added.
